Editors-in-Chief

  • Steven Curley, Baylor College of Medicine
  • Fred J. Currell, Queen's University Belfast

Now accepting submissions

Cancer Nanotechnology is accepting submissions; please use the online submission system to submit your manuscript. If you are submitting a manuscript to a particular Special Issue, please refer to its specific name in your covering letter. For all enquiries about the journal, please contact: editorial@cancer-nano.com.

Editorial Board

Editors-in-Chief

  • Steven Curley, Baylor College of Medicine, USA
  • Fred J. Currell, Queen's University Belfast, Northern Ireland

Managing Editor

  • Mark Bellringer, London, United Kingdom

Editorial Board

  • Sonia Antoranz Contera, Oxford University, UK
  • Raj Bawa, Rensselaer Polytechnic Institute, USA
  • Mathias Brust, University of Liverpool, United Kingdom
  • Esther Chang, Georgetown University School of Medicine, United States of America
  • Wei Chen, University of Texas, USA
  • Paul K. Chu, City University of Hong Kong, Hong Kong
  • Jonathan Coulter, Queen's University Belfast, United Kingdom
  • Tejal Desai, University of California, USA
  • Marco Durante, QueenÂ’s University Belfast, United Kingdom
  • Zahi Fayad, Mount Sinai School of Medicine, USA
  • Costas Hadjipanayis, Emory University, USA
  • Hossam Haick, Israel Institute of Technology, Israel
  • Hao Hong, University of Wisconsin, USA
  • Joseph Irudayaraj, Purdue University, USA
  • Suneil Jain, Queens University Belfast, United Kingdom
  • Jorge Kohanoff, Queen's University Belfast, United Kingdom
  • sunil krishnan, MD Anderson Cancer Center, United States of America
  • Zeljka Krpetic, University College Dublin, Ireland
  • M.N.V. Ravi Kumar, Texas A&M University, USA
  • Sandrine Lacombe, University Paris-Sud, France
  • Chun Li, University of Texas, USA
  • Nigel Mason, The Open University, United Kingdom
  • Arben Merkoci, Catalan Institute of Nanoscience and Nanotechnology, Spain
  • Samir Mitragotri, University of California, USA
  • Jwa-Min Nam, Seoul National University, South Korea
  • Takuro Niidome, Kumamoto University, Japan
  • Adriele Prina-Mello, Trinity College Dublin, Ireland
  • Victor Puntes, Catalan Institute of Nanoscience and Technology, Spain
  • Giuseppe Schettino, National Physical Laboratory, United Kingdom
  • Andrej Solovyov, Frankfurt Institute for Advanced Studies (FIAS), Germany
  • Suresh Valiyaveettil, National Unviersity of Singapore, Singapore
  • Thomas Webster, Northeastern University, USA
  • Volkmar Weissig, Midwestern University, USA
  • Younan Xia, Georgia Institute of Technology, USA
  • Xiu-Ping Yan, Nankai University, China
  • G.W. Yang, Sun Yat-sen University, China
  • Xian-Da Yang, Peking Union Medical College, China

About SpringerOpen

SpringerOpenSpringerOpen is Springer’s new suite of open access journals which will cover all disciplines. SpringerOpen journals are fully and immediately open access and will publish articles under the Creative Commons Attribution license. This makes it easy for authors to fully comply with open access mandates and retain copyright. SpringerOpen journals combine open access and our expertise in delivering high-quality and rapid publications, from online submission systems and in-depth peer review to an efficient, author-friendly production process.

Aims & scope

cover

Aim:

Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas.

Scope:

Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.

Instructions for authors | FAQ

Springer Knight

SpringerOpen Newsletter

Receive periodic news and updates relating to SpringerOpen.

Submit a manuscript Sign up for article alerts Contact us Support

Indexed by

  • Academic OneFile
  • CAS
  • Embase
  • Google Scholar
  • Health Reference Center Academic
  • OCLC
  • SCImago
  • Scirus
  • Scopus
  • Summon by Serial Solutions

View all

ISSN: 1868-6966